VERTEX PHARMACEUTICALS/ US92532F1003 /
20/05/2024 10:20:28 | Diferencia +4.95 | Volumen | Bid3:01:10 | Ask3:01:10 | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
411.20EUR | +1.22% | 4 Volumen de negocios: 1,621.60 |
-Volumen de oferta: - | -Tamaño/ Volumen/ Formato de Ask: - | 105.98 mil millonesEUR | - | - |
GlobeNewswire
3:00
Volvo Trucks North America and Volvo Financial Services Launch Volvo on Demand to Accelerate Battery...
GlobeNewswire
3:00
TREACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Treace Medical Concepts, Inc. on Behalf o...
GlobeNewswire
3:00
GROCERY OUTLET ALERT: Bragar Eagel & Squire, P.C. is Investigating Grocery Outlet Holding Corp. on B...
GlobeNewswire
3:00
VESTIS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Again...
GlobeNewswire
2:25
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
GlobeNewswire
2:00
AST Mining Unveils Free Cloud Mining, Paving the Way for Seamless Crypto Investment in 2024.
GlobeNewswire
2:00
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Inari Medical, Inc. Investors to Secure Counsel Be...
GlobeNewswire
1:46
Telix Completes Proof-of-Concept Study of TLX592 Targeted Alpha Therapy in Prostate Cancer
GlobeNewswire
1:11
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Be...
Newsfile Corp
1:04
SEC Issues Exemptive Order Providing Additional Time for Certain Registrants to File Quarterly Repor...
GlobeNewswire
0:53
ROSEN, LEADING INVESTOR COUNSEL, Encourages Intel Corporation Investors to Secure Counsel Before Imp...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página